HROW
HROW
NASDAQ · Pharmaceuticals

Harrow Inc

$34.20
+0.28 (+0.83%)
As of Sep 22, 1:40 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -28.0% upside
Low Target $15.17
Average Target $24.64
High Target $37.47
Current Price $34.20
Current
$34.20
Target
$24.64
$15.17 $24.64 avg $37.47
Scenario Analysis
Bear Case
$15.17
-55.6%
Low target
Base Case
$24.64
-28.0%
Avg target
Bull Case
$37.47
+9.6%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$54.85
-37.6% from high
52-Week Low
$28.54
+19.8% from low
Target vs 52W High
$24.64
-55.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%